+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Horseradish Peroxidase Market: Global Opportunity Analysis and Industry Forecast, 2024-2033

  • PDF Icon

    Report

  • 280 Pages
  • September 2024
  • Region: Global
  • Allied Market Research
  • ID: 6054021
Description Jump to:

Horseradish Peroxidase (HRP) Market

The horseradish peroxidase (HRP) market was valued at $59.1 million in 2023 and is projected to reach $115.2 million by 2033, growing at a CAGR of 6.9% from 2024 to 2033.

Horseradish peroxidase (HRP) is a glycoprotein extracted from horseradish, a root vegetable. It is a heme group-containing enzyme used for the catalysis of oxidative reactions. The enzyme finds applications in several immunoassays as it generates a luminescent derivative upon infusion with an appropriate substrate. Hence, detection and quantification are the key attributes of HRP.

Expansion of the biotechnology and diagnostics industry has upsurged the requirement for HRP, propelling the development of the market. In addition, innovations in medical R&D have augmented the horseradish peroxidase (HRP) market as the enzyme is significantly being incorporated into biosensors and drug development procedures. Furthermore, expansion of the precision medicine landscape drives the market growth as several tests and assays are conducted for the development of personalized treatments for individuals.

In recent times, explorations regarding the modification of HRP to amplify its potential and applications are trending in the market. Scientists are creating mimic enzymes with the ability to bind to nanomaterials & polymers to examine and intensify the catalytic activity & stability of HRP. These explorations are expected to extend the applicability of the enzyme in the life sciences industry.

However, the quick reaction time of HRP restricts its utility across applications with extended reaction times, hindering the development of the market. Moreover, sensitivity of HRP toward light deters several researchers from utilizing it as a potential enzyme for chemical reactions and assays. Hence, the light-sensitive nature of HRP hampers the market growth notably.

On the contrary, as the popularity of portable diagnostic kits is increasing, the horseradish peroxidase (HRP) market is witnessing several lucrative opportunities. Several research facilities and healthcare firms are focusing on the development of rapid diagnostic kits for the detection of different diseases & health conditions, hence opening new avenues for the market.

Segment Review

The horseradish peroxidase (HRP) market is segmented into substrate, application, end user, and region. On the basis of substrate, the market is divided into chromogenic, chemiluminescent, and others. Depending on application, it is bifurcated into immunoassays and biosensors. According to end user, it is classified into diagnostic centers, biopharmaceutical companies, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

On the basis of substrate, the chromogenic segment held a high share of the market in 2023.

Depending on application, the immunoassays segment dominated the market in 2023.

According to end user, the biopharmaceutical companies segment is projected to account for a high market share during the forecast period.

Region wise, North America was the highest revenue generator in 2023.

Competition Analysis

The leading players operating in the global horseradish peroxidase (HRP) market include Abcam Limited, Abnova Corporation, BBI Solutions, Bio-Rad Laboratories, Inc., Creative Enzymes, Enzo Life Sciences, Inc., F. Hoffman-La Roche Ltd., Faizyme Laboratories (Pty) Ltd., GenScript, and Merck KGaA. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the competitive market.

Additional benefits you will get with this purchase are:

  • Quarterly Update* (with the purchase of an enterprise license)
  • 5 additional Company Profiles, pre- or post-purchase, as a free update.
  • Free Updated Version (once released) with the purchase of an enterprise user license.
  • 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
  • 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
  • Free data Pack on the Enterprise User License. (Excel version of the report)
  • Free Updated report if the report is 6-12 months old or older.
  • 24-hour priority response*
  • Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

  • Patient/epidemiology data at country, region, global level
  • Regulatory Guidelines
  • Additional company profiles with specific to client's interest
  • Additional country or region analysis- market size and forecast
  • Expanded list for Company Profiles
  • Historic market data
  • SWOT Analysis

Key Market Segments

By Substrate

  • Chromogenic
  • Chemiluminescent
  • Others

By Application

  • Immunoassays
  • Biosensors

By End User

  • Diagnostic Centers
  • Biopharmaceutical Companies
  • Others

By Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
  • LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players

  • Abcam Limited
  • Abnova Corporation
  • BBI Solutions
  • Bio-Rad Laboratories, Inc.
  • Creative Enzymes
  • Enzo Life Sciences, Inc.
  • F. Hoffman-La Roche Ltd.
  • Faizyme Laboratories (Pty) Ltd.
  • GenScript
  • Merck KGaA

Please note:

  • Online Access price format is valid for 60 days access. Printing is not enabled.
  • PDF Single and Enterprise price formats enable printing.

 

Table of Contents

CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: HORSERADISH PEROXIDASE (HRP) MARKET, BY SUBSTRATE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Substrate
4.2. Chromogenic
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Chemiluminescent
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Others
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
CHAPTER 5: HORSERADISH PEROXIDASE (HRP) MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Immunoassays
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Biosensors
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
CHAPTER 6: HORSERADISH PEROXIDASE (HRP) MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Diagnostic Centers
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Biopharmaceutical Companies
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: HORSERADISH PEROXIDASE (HRP) MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Substrate
7.2.3. Market Size and Forecast, By Application
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Horseradish Peroxidase (HRP) Market
7.2.6.1. Market Size and Forecast, By Substrate
7.2.6.2. Market Size and Forecast, By Application
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Horseradish Peroxidase (HRP) Market
7.2.7.1. Market Size and Forecast, By Substrate
7.2.7.2. Market Size and Forecast, By Application
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Horseradish Peroxidase (HRP) Market
7.2.8.1. Market Size and Forecast, By Substrate
7.2.8.2. Market Size and Forecast, By Application
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Substrate
7.3.3. Market Size and Forecast, By Application
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. France Horseradish Peroxidase (HRP) Market
7.3.6.1. Market Size and Forecast, By Substrate
7.3.6.2. Market Size and Forecast, By Application
7.3.6.3. Market Size and Forecast, By End User
7.3.7. Germany Horseradish Peroxidase (HRP) Market
7.3.7.1. Market Size and Forecast, By Substrate
7.3.7.2. Market Size and Forecast, By Application
7.3.7.3. Market Size and Forecast, By End User
7.3.8. Italy Horseradish Peroxidase (HRP) Market
7.3.8.1. Market Size and Forecast, By Substrate
7.3.8.2. Market Size and Forecast, By Application
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Spain Horseradish Peroxidase (HRP) Market
7.3.9.1. Market Size and Forecast, By Substrate
7.3.9.2. Market Size and Forecast, By Application
7.3.9.3. Market Size and Forecast, By End User
7.3.10. UK Horseradish Peroxidase (HRP) Market
7.3.10.1. Market Size and Forecast, By Substrate
7.3.10.2. Market Size and Forecast, By Application
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest Of Europe Horseradish Peroxidase (HRP) Market
7.3.11.1. Market Size and Forecast, By Substrate
7.3.11.2. Market Size and Forecast, By Application
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Substrate
7.4.3. Market Size and Forecast, By Application
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. China Horseradish Peroxidase (HRP) Market
7.4.6.1. Market Size and Forecast, By Substrate
7.4.6.2. Market Size and Forecast, By Application
7.4.6.3. Market Size and Forecast, By End User
7.4.7. Japan Horseradish Peroxidase (HRP) Market
7.4.7.1. Market Size and Forecast, By Substrate
7.4.7.2. Market Size and Forecast, By Application
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Horseradish Peroxidase (HRP) Market
7.4.8.1. Market Size and Forecast, By Substrate
7.4.8.2. Market Size and Forecast, By Application
7.4.8.3. Market Size and Forecast, By End User
7.4.9. South Korea Horseradish Peroxidase (HRP) Market
7.4.9.1. Market Size and Forecast, By Substrate
7.4.9.2. Market Size and Forecast, By Application
7.4.9.3. Market Size and Forecast, By End User
7.4.10. Australia Horseradish Peroxidase (HRP) Market
7.4.10.1. Market Size and Forecast, By Substrate
7.4.10.2. Market Size and Forecast, By Application
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Horseradish Peroxidase (HRP) Market
7.4.11.1. Market Size and Forecast, By Substrate
7.4.11.2. Market Size and Forecast, By Application
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Substrate
7.5.3. Market Size and Forecast, By Application
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Horseradish Peroxidase (HRP) Market
7.5.6.1. Market Size and Forecast, By Substrate
7.5.6.2. Market Size and Forecast, By Application
7.5.6.3. Market Size and Forecast, By End User
7.5.7. South Africa Horseradish Peroxidase (HRP) Market
7.5.7.1. Market Size and Forecast, By Substrate
7.5.7.2. Market Size and Forecast, By Application
7.5.7.3. Market Size and Forecast, By End User
7.5.8. Saudi Arabia Horseradish Peroxidase (HRP) Market
7.5.8.1. Market Size and Forecast, By Substrate
7.5.8.2. Market Size and Forecast, By Application
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Horseradish Peroxidase (HRP) Market
7.5.9.1. Market Size and Forecast, By Substrate
7.5.9.2. Market Size and Forecast, By Application
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. Abcam Limited
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Abnova Corporation
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. BBI Solutions
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. Bio-Rad Laboratories, Inc.
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. Creative Enzymes
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Enzo Life Sciences, Inc.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. F. Hoffman-La Roche Ltd.
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Faizyme Laboratories (Pty) Ltd.
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. GenScript
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Merck KGaA
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
LIST OF TABLES
Table 1. Global Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 2. Horseradish Peroxidase (Hrp) Market for Chromogenic, by Region, 2024 - 2033 ($Million)
Table 3. Horseradish Peroxidase (Hrp) Market for Chemiluminescent, by Region, 2024 - 2033 ($Million)
Table 4. Horseradish Peroxidase (Hrp) Market for Others, by Region, 2024 - 2033 ($Million)
Table 5. Global Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 6. Horseradish Peroxidase (Hrp) Market for Immunoassays, by Region, 2024 - 2033 ($Million)
Table 7. Horseradish Peroxidase (Hrp) Market for Biosensors, by Region, 2024 - 2033 ($Million)
Table 8. Global Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 9. Horseradish Peroxidase (Hrp) Market for Diagnostic Centers, by Region, 2024 - 2033 ($Million)
Table 10. Horseradish Peroxidase (Hrp) Market for Biopharmaceutical Companies, by Region, 2024 - 2033 ($Million)
Table 11. Horseradish Peroxidase (Hrp) Market for Others, by Region, 2024 - 2033 ($Million)
Table 12. Horseradish Peroxidase (Hrp) Market, by Region, 2024 - 2033 ($Million)
Table 13. North America Horseradish Peroxidase (Hrp) Market, by Country, 2024 - 2033 ($Million)
Table 14. North America Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 15. North America Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 16. North America Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 17. U.S. Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 18. U.S. Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 19. U.S. Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 20. Canada Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 21. Canada Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 22. Canada Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 23. Mexico Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 24. Mexico Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 25. Mexico Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 26. Europe Horseradish Peroxidase (Hrp) Market, by Country, 2024 - 2033 ($Million)
Table 27. Europe Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 28. Europe Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 29. Europe Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 30. France Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 31. France Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 32. France Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 33. Germany Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 34. Germany Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 35. Germany Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 36. Italy Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 37. Italy Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 38. Italy Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 39. Spain Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 40. Spain Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 41. Spain Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 42. UK Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 43. UK Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 44. UK Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 45. Rest of Europe Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 46. Rest of Europe Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 47. Rest of Europe Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 48. Asia-Pacific Horseradish Peroxidase (Hrp) Market, by Country, 2024 - 2033 ($Million)
Table 49. Asia-Pacific Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 50. Asia-Pacific Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 51. Asia-Pacific Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 52. China Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 53. China Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 54. China Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 55. Japan Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 56. Japan Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 57. Japan Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 58. India Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 59. India Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 60. India Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 61. South Korea Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 62. South Korea Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 63. South Korea Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 64. Australia Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 65. Australia Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 66. Australia Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 67. Rest of Asia-Pacific Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 68. Rest of Asia-Pacific Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 69. Rest of Asia-Pacific Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 70. LAMEA Horseradish Peroxidase (Hrp) Market, by Country, 2024 - 2033 ($Million)
Table 71. LAMEA Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 72. LAMEA Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 73. LAMEA Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 74. Brazil Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 75. Brazil Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 76. Brazil Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 77. South Africa Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 78. South Africa Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 79. South Africa Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 80. Saudi Arabia Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 81. Saudi Arabia Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 82. Saudi Arabia Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 83. Rest of LAMEA Horseradish Peroxidase (Hrp) Market, by Substrate, 2024 - 2033 ($Million)
Table 84. Rest of LAMEA Horseradish Peroxidase (Hrp) Market, by Application, 2024 - 2033 ($Million)
Table 85. Rest of LAMEA Horseradish Peroxidase (Hrp) Market, by End-user, 2024 - 2033 ($Million)
Table 86. Abcam Limited: Key Executives
Table 87. Abcam Limited: Company Snapshot
Table 88. Abcam Limited: Operating Segments
Table 89. Abcam Limited: Product Portfolio
Table 90. Abcam Limited: Key Strategic Moves and Developments
Table 91. Abnova Corporation: Key Executives
Table 92. Abnova Corporation: Company Snapshot
Table 93. Abnova Corporation: Operating Segments
Table 94. Abnova Corporation: Product Portfolio
Table 95. Abnova Corporation: Key Strategic Moves and Developments
Table 96. Bbi Solutions: Key Executives
Table 97. Bbi Solutions: Company Snapshot
Table 98. Bbi Solutions: Operating Segments
Table 99. Bbi Solutions: Product Portfolio
Table 100. Bbi Solutions: Key Strategic Moves and Developments
Table 101. Bio-Rad Laboratories, Inc.: Key Executives
Table 102. Bio-Rad Laboratories, Inc.: Company Snapshot
Table 103. Bio-Rad Laboratories, Inc.: Operating Segments
Table 104. Bio-Rad Laboratories, Inc.: Product Portfolio
Table 105. Bio-Rad Laboratories, Inc.: Key Strategic Moves and Developments
Table 106. Creative Enzymes: Key Executives
Table 107. Creative Enzymes: Company Snapshot
Table 108. Creative Enzymes: Operating Segments
Table 109. Creative Enzymes: Product Portfolio
Table 110. Creative Enzymes: Key Strategic Moves and Developments
Table 111. Enzo Life Sciences, Inc.: Key Executives
Table 112. Enzo Life Sciences, Inc.: Company Snapshot
Table 113. Enzo Life Sciences, Inc.: Operating Segments
Table 114. Enzo Life Sciences, Inc.: Product Portfolio
Table 115. Enzo Life Sciences, Inc.: Key Strategic Moves and Developments
Table 116. F. Hoffman-La Roche Ltd.: Key Executives
Table 117. F. Hoffman-La Roche Ltd.: Company Snapshot
Table 118. F. Hoffman-La Roche Ltd.: Operating Segments
Table 119. F. Hoffman-La Roche Ltd.: Product Portfolio
Table 120. F. Hoffman-La Roche Ltd.: Key Strategic Moves and Developments
Table 121. Faizyme Laboratories (Pty) Ltd.: Key Executives
Table 122. Faizyme Laboratories (Pty) Ltd.: Company Snapshot
Table 123. Faizyme Laboratories (Pty) Ltd.: Operating Segments
Table 124. Faizyme Laboratories (Pty) Ltd.: Product Portfolio
Table 125. Faizyme Laboratories (Pty) Ltd.: Key Strategic Moves and Developments
Table 126. Genscript: Key Executives
Table 127. Genscript: Company Snapshot
Table 128. Genscript: Operating Segments
Table 129. Genscript: Product Portfolio
Table 130. Genscript: Key Strategic Moves and Developments
Table 131. Merck KGaA: Key Executives
Table 132. Merck KGaA: Company Snapshot
Table 133. Merck KGaA: Operating Segments
Table 134. Merck KGaA: Product Portfolio
Table 135. Merck KGaA: Key Strategic Moves and Developments
LIST OF FIGURES
Figure 1. Global Horseradish Peroxidase (Hrp) Market, 2024 - 2033
Figure 2. Segmentation of Horseradish Peroxidase (Hrp) Market, 2024 - 2033
Figure 3. Top Investment Pocket in Horseradish Peroxidase (Hrp) Market
Figure 4. Moderate Bargaining Power of Buyers
Figure 5. Moderate Bargaining Power of Suppliers
Figure 6. Moderate Threat of New Entrants
Figure 7. Low Threat of Substitution
Figure 8. High Competitive Rivalry
Figure 9. Opportunities, Restraints and Drivers: Globalhorseradish Peroxidase (Hrp) Market
Figure 10. Global Horseradish Peroxidase (Hrp) Market Segmentation, by Substrate
Figure 11. Horseradish Peroxidase (Hrp) Market for Chromogenic, by Country, 2024 - 2033 ($Million)
Figure 12. Horseradish Peroxidase (Hrp) Market for Chemiluminescent, by Country, 2024 - 2033 ($Million)
Figure 13. Horseradish Peroxidase (Hrp) Market for Others, by Country, 2024 - 2033 ($Million)
Figure 14. Global Horseradish Peroxidase (Hrp) Market Segmentation, by Application
Figure 15. Horseradish Peroxidase (Hrp) Market for Immunoassays, by Country, 2024 - 2033 ($Million)
Figure 16. Horseradish Peroxidase (Hrp) Market for Biosensors, by Country, 2024 - 2033 ($Million)
Figure 17. Global Horseradish Peroxidase (Hrp) Market Segmentation, by End-user
Figure 18. Horseradish Peroxidase (Hrp) Market for Diagnostic Centers, by Country, 2024 - 2033 ($Million)
Figure 19. Horseradish Peroxidase (Hrp) Market for Biopharmaceutical Companies, by Country, 2024 - 2033 ($Million)
Figure 20. Horseradish Peroxidase (Hrp) Market for Others, by Country, 2024 - 2033 ($Million)
Figure 21. Top Winning Strategies, by Year, 2021-2023*
Figure 22. Top Winning Strategies, by Development, 2021-2023*
Figure 23. Top Winning Strategies, by Company, 2021-2023*
Figure 24. Product Mapping of Top 10 Players
Figure 25. Competitive Dashboard
Figure 26. Competitive Heatmap: Horseradish Peroxidase (Hrp) Market
Figure 27. Top Player Positioning, 2023
Figure 28. Abcam Limited: Net Sales, 2021-2023 ($Million)
Figure 29. Abcam Limited: Revenue Share, by Segment, 2023 (%)
Figure 30. Abcam Limited: Revenue Share, by Region, 2023 (%)
Figure 31. Abnova Corporation: Net Sales, 2021-2023 ($Million)
Figure 32. Abnova Corporation: Revenue Share, by Segment, 2023 (%)
Figure 33. Abnova Corporation: Revenue Share, by Region, 2023 (%)
Figure 34. Bbi Solutions: Net Sales, 2021-2023 ($Million)
Figure 35. Bbi Solutions: Revenue Share, by Segment, 2023 (%)
Figure 36. Bbi Solutions: Revenue Share, by Region, 2023 (%)
Figure 37. Bio-Rad Laboratories, Inc.: Net Sales, 2021-2023 ($Million)
Figure 38. Bio-Rad Laboratories, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 39. Bio-Rad Laboratories, Inc.: Revenue Share, by Region, 2023 (%)
Figure 40. Creative Enzymes: Net Sales, 2021-2023 ($Million)
Figure 41. Creative Enzymes: Revenue Share, by Segment, 2023 (%)
Figure 42. Creative Enzymes: Revenue Share, by Region, 2023 (%)
Figure 43. Enzo Life Sciences, Inc.: Net Sales, 2021-2023 ($Million)
Figure 44. Enzo Life Sciences, Inc.: Revenue Share, by Segment, 2023 (%)
Figure 45. Enzo Life Sciences, Inc.: Revenue Share, by Region, 2023 (%)
Figure 46. F. Hoffman-La Roche Ltd.: Net Sales, 2021-2023 ($Million)
Figure 47. F. Hoffman-La Roche Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 48. F. Hoffman-La Roche Ltd.: Revenue Share, by Region, 2023 (%)
Figure 49. Faizyme Laboratories (Pty) Ltd.: Net Sales, 2021-2023 ($Million)
Figure 50. Faizyme Laboratories (Pty) Ltd.: Revenue Share, by Segment, 2023 (%)
Figure 51. Faizyme Laboratories (Pty) Ltd.: Revenue Share, by Region, 2023 (%)
Figure 52. Genscript: Net Sales, 2021-2023 ($Million)
Figure 53. Genscript: Revenue Share, by Segment, 2023 (%)
Figure 54. Genscript: Revenue Share, by Region, 2023 (%)
Figure 55. Merck KGaA: Net Sales, 2021-2023 ($Million)
Figure 56. Merck KGaA: Revenue Share, by Segment, 2023 (%)
Figure 57. Merck KGaA: Revenue Share, by Region, 2023 (%)

Companies Mentioned

  • Abcam Limited
  • Abnova Corporation
  • BBI Solutions
  • Bio-Rad Laboratories, Inc.
  • Creative Enzymes
  • Enzo Life Sciences, Inc.
  • F. Hoffman-La Roche Ltd.
  • Faizyme Laboratories (Pty) Ltd.
  • GenScript
  • Merck KGaA

Methodology

The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.

They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.

They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic news articles and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast

Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages280
PublishedSeptember 2024
Forecast Period2023 - 2033
Estimated Market Value ( USD ) in 2023 $ 59.1 million
Forecasted Market Value ( USD ) by 2033 $ 115.2 million
Compound Annual Growth Rate6.9%
Regions CoveredGlobal
No. of Companies Mentioned10

Related Topics

Related Reports

Horseradish Peroxidase Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F - Product Image

Horseradish Peroxidase Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F

  • Report
  • 182 Pages
  • Global
From
Enzyme Nanoarchitectures: Enzymes Armored with Graphene. Methods in Enzymology Volume 609 - Product Image

Enzyme Nanoarchitectures: Enzymes Armored with Graphene. Methods in Enzymology Volume 609

  • Book
Enzymatic Polymerizations. Methods in Enzymology Volume 627 - Product Image

Enzymatic Polymerizations. Methods in Enzymology Volume 627

  • Book
  • 380 Pages
In Vitro Diagnostics Enzymes Market Report 2025 - Product Image

In Vitro Diagnostics Enzymes Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Diagnostic Enzymes Market Size, Share & Trends Analysis Report by Type (Taq Polymerase, MMLV RT, HIV RT), Application (Diabetes, Oncology, Cardiology), Product, End-use, Region, and Segment Forecasts, 2025-2030 - Product Image

Diagnostic Enzymes Market Size, Share & Trends Analysis Report by Type (Taq Polymerase, MMLV RT, HIV RT), Application (Diabetes, Oncology, Cardiology), Product, End-use, Region, and Segment Forecasts, 2025-2030

  • Report
  • 120 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.